33rd German Cancer Congress Tecentriq shows a long Response and a median Overall Survival of 15.9 Months in Patients with mUC

[Anonymous]

ONCOLOGY RESEARCH AND TREATMENT, 2018; 41 (4): 244

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索